Skip to content

The Effect of Zinc on the Gingival Crevicular Fluid Level of Total Oxidant Capacity in Type 2 Diabetic Patients

The Effect of Systemic Administration of Zinc on the Gingival Crevicular Fluid Level of Total Oxidant Capacity in Type 2 Diabetic Patients With Stage II and III Periodontitis After Non-surgical Periodontal Therapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03923829
Enrollment
34
Registered
2019-04-23
Start date
2019-04-30
Completion date
2020-08-30
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis

Keywords

zinc, Non-surgical Periodontal Therapy, stage II periodontitis, stage III periodontitis, gingival crevicular fluid, total oxidant capacity, Type 2 diabetic patients

Brief summary

To evaluate the effect of systemic administration of zinc on the gingival crevicular fluid level of total oxidant capacity in controlled Type-2 diabetic patients with stage-II and III periodontitis after non-surgical periodontal therapy.

Detailed description

Hypozincaemia and hyperzincuria is known to be present in patients with type-2 diabetes, and Zinc supplementation is known to be helpful in restoring plasma Zinc levels to normal,Zinc's deficiency can lead to an increase in circulating glucose due to beta cells malfunctioning and resistance to insulin, which makes it easier for type 2 diabetes mellitus (DM2) to happen ,Zinc was found to be a structural part of key anti-oxidant enzymes such as superoxide dismutase (SOD), and Zinc deficiency impaired their synthesis, leading to increased oxidative stress

Interventions

DRUGZinc Sulfate

systemic administration of Zinc sulfate with scaling and root planing

PROCEDUREscaling and root planing

scaling and root planing

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The outcome assessor and statistician will be blinded to the intervention

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Controlled Type-2 diabetes mellitus * Stage-II &III periodontitis * At least 2 sites with clinical attachment loss 3 or 4 mm to ≥5 mm and radiographic bone loss 15% Extending to mid-third of root and beyond. * Probing depth from ≤5 mm to ≥6 mm

Exclusion criteria

* Any periodontal or Antibiotic treatment during the last six months. * Receiving trace element supplements in the previous three months * Pregnant or lactating females * Gastric or diuretic treatment * Acute renal failure * smoking

Design outcomes

Primary

MeasureTime frame
change from baseline Hb-A1cchange from baseline Hb-A1c at 3 monthes

Secondary

MeasureTime frameDescription
Hb-A1cat the baseline and after 3 monthsHb-A1c
Probing pocket depthat the baseline and after 3 monthsProbing pocket depth Measured as the distance between the gingival margin and the apical part of the pocket will be measured using William's graduated periodontal probe.
Clinical attachment levelat the baseline and after 3 monthsIt will be measured from the cemento-enamel junction till the apical part of the pocket.
Gingival indexat the baseline and after 3 monthsGingival Index for a specific tooth == Average (points for the 4 surfaces)

Contacts

Primary Contactabdulrahman A Abdulrab
abdulrahman.awadh@dentistry.cu.edu.eg+201014624724
Backup ContactDr. Enji Ahmed, professor
enji.ahmed@dentistry.cu.edu.eg+201018941119

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026